Caris Life Sciences Inc (CAI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2011 | 12-2010 | 12-2009 | 12-2008 | 12-2007 | |
| Sales | 125,706 | 77,899 | 65,264 | 83,145 | 64,872 |
| Gross Profit | 125,706 | 77,899 | 65,264 | 83,145 | 64,872 |
| Operating Expenses | 47,681 | 40,973 | 43,488 | 89,434 | 24,937 |
| Operating Income | 78,025 | 36,926 | 21,776 | -6,289 | 39,935 |
| Interest Expense | 16,139 | 5,278 | 4,311 | 9,346 | 10,705 |
| Other Income | 12 | 109 | 10 | 229 | 807 |
| Pre-tax Income | 61,898 | 31,757 | 17,475 | -15,406 | 30,037 |
| Income Tax | 11,084 | 3,555 | 3,919 | 11,547 | 10,990 |
| Net Income Continuous | 50,814 | 28,202 | 13,556 | -26,953 | 19,047 |
| Minority Interests | 625 | -181 | 0 | N/A | N/A |
| Net Income | $50,189 | $28,383 | $13,556 | $-26,953 | $19,047 |
| EPS Basic Total Ops | 2.60 | 1.58 | 0.76 | -1.55 | 0.92 |
| EPS Basic Continuous Ops | 2.63 | 1.57 | 0.76 | -1.55 | 1.29 |
| EPS Diluted Total Ops | 2.55 | 1.56 | 0.76 | -1.55 | 0.85 |
| EPS Diluted Continuous Ops | 2.58 | 1.55 | 0.76 | -1.55 | 1.14 |
| EBITDA(a) | $114,778 | $60,008 | $41,290 | $61,967 | $50,709 |